Impact of Ribosome Activity on SARS-CoV-2 LNP – Based mRNA Vaccines

Impact of Ribosome Activity on SARS-CoV-2 LNP – Based mRNA Vaccines

Coronavirus-related Severe Acute Respiratory Syndrome-2 (SARS-CoV-2) initially was detected in Wuhan, Hubei, China. Since early 2021, World Health Organization (WHO) has declared Coronavirus Disease 2019 (COVID-19) a pandemic due to rapidly transformed to a globally massive catastrophic viral infect...

Full description

Bibliographic Details
Main Authors: Evangelos Tsiambas, Aristeidis Chrysovergis, Vasileios Papanikolaou, Nicholas Mastronikolis, Vasileios Ragos, Anna Batistatou, Dimitrios Peschos, Nikolaos Kavantzas, Andreas C. Lazaris, Efthimios Kyrodimos
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Molecular Biosciences
Subjects:
ribosome
mRNA
SARS-CoV-2
COVID-19
vaccine
LNP
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.654866/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2021.654866/full

Similar Items